Issue Date: June 6, 2011
GSK, MaRS Innovation Establish R&D Fund
GlaxoSmithKline and MaRS Innovation, a Toronto-based nonprofit that commercializes intellectual property generated by local institutions, have established a new fund devoted to pulling research out of 16 Canadian academic institutions and hospitals and accelerating its translation into commercial products. The GSK-MaRS Innovation Fund will support research in drug development, diagnostics, and health care delivery technologies. The three-year partnership with GSK marks the second development fund launched by MaRS Innovation.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society